Mixed depression and suicidality in oncology outpatients
Introduction Mixed depression (MxD), is a nosologic entity characterized by the presence of excitatory symptoms during a depressive episode. MxD embeds high levels of chronicity, functional impairment and suicidality. The assessment of MxD in a subpopulation that features high levels of fragility,...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2023-03-01
|
| Series: | European Psychiatry |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823007848/type/journal_article |
| _version_ | 1797616016308568064 |
|---|---|
| author | E. Bernardi A. Catinari O. M. Ferrara G. Bartolucci M. Ciliberto G. Carriero L. Di Benedetto E. M. Marzo G. Donofrio S. Ruggiero G. Sani A. Simonetti |
| author_facet | E. Bernardi A. Catinari O. M. Ferrara G. Bartolucci M. Ciliberto G. Carriero L. Di Benedetto E. M. Marzo G. Donofrio S. Ruggiero G. Sani A. Simonetti |
| author_sort | E. Bernardi |
| collection | DOAJ |
| description |
Introduction
Mixed depression (MxD), is a nosologic entity characterized by the presence of excitatory symptoms during a depressive episode. MxD embeds high levels of chronicity, functional impairment and suicidality. The assessment of MxD in a subpopulation that features high levels of fragility, such as oncology patients, represent a pivotal strategy to reduce illness burden and suicidality in these subjects
Objectives
The aim of the present project is to assess the characteristics of MxD in oncology outpatients and to compare them with those of outpatients without oncological comorbidity.
Methods
Forty-two oncology outpatients with MxD (ONC-MxD); 34 oncology outpatients and inhibited depression (ONC-inhib); 187 outpatients with MxD without oncological comorbidity (MxD); 224 outpatients with inhibited depression without oncological comorbidity (Inhib) and 168 healthy controls (HC) have been recruited. Analyses made include comparisons of demographic and clinical variables, depression severity, excitatory symptoms, suicidality and functional impairment.
Results
Oncology outpatients with depressive disorder showed greater severity of depressive symptoms and greater functional impairment than those without oncological comorbidity (F=187.08; p<.001; F=54.08; p<.001, respectively). ONC-inhib showed greater inhibition than Inhib (p<.001), whereas no differences in levels of excitatory symptoms are present between MxD e ONC-MxD (p=.159). ONC-DMX have a more recent diagnosis of cancer than ONC-inib (F=13.39, p<.001) and higher rates of suicidal ideation (χ²=11.89; p=.008).
Conclusions
Cancer might worsen depression severity, especially in its inhibitory component. Relationships between onset of cancer, excitatory symptoms and suicidality suggest that the period following the diagnosis of cancer is the one at higher risk for suicide. Strategies aiming to treat excitatory symptoms in such period might help reduce risk of suicide in oncology patients.
Disclosure of Interest
None Declared |
| first_indexed | 2024-03-11T07:35:11Z |
| format | Article |
| id | doaj.art-b8237c92922947d7864cd65bb93931d3 |
| institution | Directory Open Access Journal |
| issn | 0924-9338 1778-3585 |
| language | English |
| last_indexed | 2024-03-11T07:35:11Z |
| publishDate | 2023-03-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj.art-b8237c92922947d7864cd65bb93931d32023-11-17T05:10:15ZengCambridge University PressEuropean Psychiatry0924-93381778-35852023-03-0166S360S36110.1192/j.eurpsy.2023.784Mixed depression and suicidality in oncology outpatientsE. Bernardi0A. Catinari1O. M. Ferrara2G. Bartolucci3M. Ciliberto4G. Carriero5L. Di Benedetto6E. M. Marzo7G. Donofrio8S. Ruggiero9G. Sani10A. Simonetti11Neuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCSNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, Rome, ItalyNeuroscience, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, United States Introduction Mixed depression (MxD), is a nosologic entity characterized by the presence of excitatory symptoms during a depressive episode. MxD embeds high levels of chronicity, functional impairment and suicidality. The assessment of MxD in a subpopulation that features high levels of fragility, such as oncology patients, represent a pivotal strategy to reduce illness burden and suicidality in these subjects Objectives The aim of the present project is to assess the characteristics of MxD in oncology outpatients and to compare them with those of outpatients without oncological comorbidity. Methods Forty-two oncology outpatients with MxD (ONC-MxD); 34 oncology outpatients and inhibited depression (ONC-inhib); 187 outpatients with MxD without oncological comorbidity (MxD); 224 outpatients with inhibited depression without oncological comorbidity (Inhib) and 168 healthy controls (HC) have been recruited. Analyses made include comparisons of demographic and clinical variables, depression severity, excitatory symptoms, suicidality and functional impairment. Results Oncology outpatients with depressive disorder showed greater severity of depressive symptoms and greater functional impairment than those without oncological comorbidity (F=187.08; p<.001; F=54.08; p<.001, respectively). ONC-inhib showed greater inhibition than Inhib (p<.001), whereas no differences in levels of excitatory symptoms are present between MxD e ONC-MxD (p=.159). ONC-DMX have a more recent diagnosis of cancer than ONC-inib (F=13.39, p<.001) and higher rates of suicidal ideation (χ²=11.89; p=.008). Conclusions Cancer might worsen depression severity, especially in its inhibitory component. Relationships between onset of cancer, excitatory symptoms and suicidality suggest that the period following the diagnosis of cancer is the one at higher risk for suicide. Strategies aiming to treat excitatory symptoms in such period might help reduce risk of suicide in oncology patients. Disclosure of Interest None Declaredhttps://www.cambridge.org/core/product/identifier/S0924933823007848/type/journal_article |
| spellingShingle | E. Bernardi A. Catinari O. M. Ferrara G. Bartolucci M. Ciliberto G. Carriero L. Di Benedetto E. M. Marzo G. Donofrio S. Ruggiero G. Sani A. Simonetti Mixed depression and suicidality in oncology outpatients European Psychiatry |
| title | Mixed depression and suicidality in oncology outpatients |
| title_full | Mixed depression and suicidality in oncology outpatients |
| title_fullStr | Mixed depression and suicidality in oncology outpatients |
| title_full_unstemmed | Mixed depression and suicidality in oncology outpatients |
| title_short | Mixed depression and suicidality in oncology outpatients |
| title_sort | mixed depression and suicidality in oncology outpatients |
| url | https://www.cambridge.org/core/product/identifier/S0924933823007848/type/journal_article |
| work_keys_str_mv | AT ebernardi mixeddepressionandsuicidalityinoncologyoutpatients AT acatinari mixeddepressionandsuicidalityinoncologyoutpatients AT omferrara mixeddepressionandsuicidalityinoncologyoutpatients AT gbartolucci mixeddepressionandsuicidalityinoncologyoutpatients AT mciliberto mixeddepressionandsuicidalityinoncologyoutpatients AT gcarriero mixeddepressionandsuicidalityinoncologyoutpatients AT ldibenedetto mixeddepressionandsuicidalityinoncologyoutpatients AT emmarzo mixeddepressionandsuicidalityinoncologyoutpatients AT gdonofrio mixeddepressionandsuicidalityinoncologyoutpatients AT sruggiero mixeddepressionandsuicidalityinoncologyoutpatients AT gsani mixeddepressionandsuicidalityinoncologyoutpatients AT asimonetti mixeddepressionandsuicidalityinoncologyoutpatients |